1-4 of 4
Mihaela Lazaroiu
Close
Sort by
Journal Articles

Updated Results from the Momentum Phase 3 Study of Momelotinib (MMB) Versus Danazol (DAN) in Symptomatic and Anemic Myelofibrosis (MF) Patients Previously Treated with a JAK Inhibitor

Aaron T. Gerds, Ruben Mesa, Alessandro M Vannucchi, Haifa Kathrin Al-Ali, David Lavie, Andrew Kuykendall, Sebastian Grosicki, Alessandra Iurlo, Yeow Tee Goh, Mihaela Lazaroiu, Miklos Egyed, Maria Laura Fox, Donal P. McLornan, Andrew Charles Perkins, Sung-Soo Yoon, Vikas Gupta, Jean-Jacques Kiladjian, Rafe Donahue, Jun Kawashima, Srdan Verstovsek
Journal: Blood
Blood (2022) 140 (Supplement 1): 1514–1517.
https://doi.org/10.1182/blood-2022-162783
Published: 2022
Journal Articles

Long-Term Outcomes and Health-Related Quality of Life (HRQoL) By Response Status for Bortezomib, Melphalan, and Prednisone (VMP) ± Daratumumab (DARA) in Alcyone

Paula Rodriguez-Otero, Mario Boccadoro, Roman Hajek, MD, Tomoaki Fujisaki, MD, Jae Hoon Lee, MD PhD, Joaquin Martinez-Lopez, MD, Paulo Lucio, MD PhD, Zsolt Nagy, MD PhD, Ganna Usenko, MD, Anna Marina Liberati, MD, Mihaela Lazaroiu, MD, Dariusz Woszczyk, MDPhD, Hiroyuki Takamatsu, MDPhD, Joanna Romejko-Jarosinska, Stefan Tobias Knop, Astrid Pavlovsky, MD, Cecily Forsyth, FRACP, FRCPA, MBBS, Takayuki Ishikawa, MD PhD, Katharine S. Gries, PhD PharmD, Huiling Pei, PhD, Anupa Kudva, MD, Jon Ukropec, PhD, Susan Wroblewski, PhD, Robin Carson, MD BA, Meletios A Dimopoulos
Journal: Blood
Blood (2020) 136 (Supplement 1): 43–44.
https://doi.org/10.1182/blood-2020-136145
Published: 2020
Journal Articles

Momelotinib's Spleen, Symptom and Anemia Efficacy Is Maintained in Intermediate/High Risk Myelofibrosis Patients with Thrombocytopenia

Jean Jacques Kiladjian, MD PhD, Uwe Platzbecker, Jiri Mayer, MD, Árpád Illés, MD PhD, Witold Prejzner, MD PhD, Tomasz Wozny, MD PhD, Nikolay Tzvetkov, MD, Alessandro M. Vannucchi, MD, Ilya Kirgner, MD, Zsolt Nagy, MD PhD, Sebastian Grosicki, MD PhD, Åsa Rangert Derolf, MDPhD, Mihaela Lazaroiu, MD, Sung-Soo Yoon, MD PhD, Yeow Tee Goh, MBBS, Nikolas Von Bubnoff, Srdan Verstovsek, MD PhD, Barbara Jane Klencke, MD, Rafe Donahue, PhD, Ruben Mesa, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 43–44.
https://doi.org/10.1182/blood-2020-135880
Published: 2020
Journal Articles

Rozrolimupab, a mixture of 25 recombinant human monoclonal RhD antibodies, in the treatment of primary immune thrombocytopenia

Clinical Trials & Observations
Tadeusz Robak, Jerzy Windyga, Jacek Trelinski, Mario von Depka Prondzinski, Aristoteles Giagounidis, Chantal Doyen, Ann Janssens, María Teresa Álvarez-Román, Isidro Jarque, Javier Loscertales, Gloria Pérez Rus, Andrzej Hellmann, Wiesław Wiktor Jêdrzejczak, Kazimierz Kuliczkowski, Lana M. Golubovic, Dusica Celeketic, Andrei Cucuianu, Emanuil Gheorghita, Mihaela Lazaroiu, Ofer Shpilberg, Dina Attias, Elena Karyagina, Kalinina Svetlana, Kateryna Vilchevska, Nichola Cooper, Kate Talks, Mukhyaprana Prabhu, Prasad Sripada, T. P. R. Bharadwaj, Henrik Næsted, Niels J. Ø. Skartved, Torben P. Frandsen, Mimi F. Flensburg, Peter S. Andersen, Jørgen Petersen
Journal: Blood
Blood (2012) 120 (18): 3670–3676.
https://doi.org/10.1182/blood-2012-06-438804
Published: 2012